Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (57.97 KB, 1 trang )
management, 754 –755
treatment, goals of, 754
Chagas disease, 846
Chalazions, 1401 –1402
chronic, 1402 f
multiple, 1401 f
Chance fractures, 1092 , 1211 f
Chancroid, 312
Charcoal therapy, 293
Charcot–Marie–Tooth disease, 305
CHARGE syndrome, 222
Chediak–Higashi syndrome, 465
Chelation therapy, 1064 t
Chemical burns, 1102 –1103
Chemical cystitis, 529
Chemical exposure, 1102 , 1400
Chest compressions, 66
Chest pain
arrhythmias and, 368
associated with mitral valve prolapse, 369
causes, 367 t
esophageal, 374
life-threatening, 368 t
cocaine exposure and, 367 –368
connective tissue disorders and, 369
differential diagnosis, 366 –370
drug exposure and, 369
in dyspneic/cyanotic patient, 366
evaluation and decision, 370 –374
child with no thoracic trauma, 372 –374
child with thoracic trauma, 370 –372